Scarica l'app Stockscreener
177.47
1.60%
-2.88
Dopo l'orario di chiusura:
177.47
Glaukos Corp Borsa (GKOS) Ultime notizie
Enterprise value to EBITDA forward of Glaukos Corp – LSX:A14VCK - TradingView
Precipio Inc. (PRPO) Peer Comparison – Compare with Others - Value Research
Mesa Laboratories Inc. (MLAB) Peer Comparison – Compare with Others - Value Research
Bruker Corporation (BRKR) Peer Comparison – Compare with Others - Value Research
Heska Corporation (HSKA) Peer Comparison – Compare with Others - Value Research
Natus Medical Incorporated (NTUS) Peer Comparison – Compare with Others - Value Research
Repro Med Systems Inc. (KRMD) Peer Comparison – Compare with Others - Value Research
Allied Healthcare Products Inc. (AHPI) Peer Comparison – Compare with Others - Value Research
Codex DNA Inc (DNAY) Peer Comparison – Compare with Others - Value Research
GlucoTrack Inc (GCTK) Peer Comparison – Compare with Others - Value Research
InspireMD Inc. (NSPR) Peer Comparison – Compare with Others - Value Research
IsoPlexis Corporation (ISO) Peer Comparison – Compare with Others - Value Research
Glaukos chief development officer sells $2.48m in shares - Investing.com
Glaukos chief development officer sells $2.48m in shares By Investing.com - Investing.com Canada
Haemonetics Corporation (HAE) Peer Comparison – Compare with Others - Value Research
Glaukos stock trades at $179 as investors weigh recent growth and valuation - AD HOC NEWS
ICU Medical Inc. (ICUI) Peer Comparison – Compare with Others - Value Research
Trinity Biotech plcADR Peer Comparison – Compare with Others - Value Research
Acutus Medical Inc (AFIB) Peer Comparison – Compare with Others - Value Research
SS Innovations International Inc. (SSII) Peer Comparison – Compare with Others - Value Research
Bioventus Inc. Class A (BVS) Peer Comparison – Compare with Others - Value Research
Omnicell Inc. ($0.001 par value) (OMCL) Peer Comparison – Compare with Others - valueresearchonline.com
MaxCyte Inc. (MXCT) Peer Comparison – Compare with Others - valueresearchonline.com
Repligen Corporation (RGEN) Peer Comparison – Compare with Others - Value Research
Glaukos Corp (GKOS) Key Financial Ratios – Valuation, Profitability & More - Value Research
Glaukos (NYSE: GKOS) insider eyes multimillion-dollar stock sale - Stock Titan
Aethlon Medical Inc. (AEMD) Peer Comparison – Compare with Others - Value Research
Vivos Therapeutics Inc. (VVOS) Peer Comparison – Compare with Others - Value Research
Dentsply Sirona Inc (XRAY) Peer Comparison – Compare with Others - Value Research
Myriad Genetics Inc. (MYGN) Peer Comparison – Compare with Others - Value Research
TransMedics Group Inc. (TMDX) Peer Comparison – Compare with Others - Value Research
Innovative Eyewear Inc (LUCYW) Peer Comparison – Compare with Others - Value Research
Glaukos Corp (GKOS) Peer Comparison – Compare with Others - Value Research
Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today - Benzinga
Why Is Glaukos (NYSE:GKOS) in Focus After Record Quarterly Sales? - Kalkine Media
Zacks Research Issues Positive Estimate for Glaukos Earnings - MarketBeat
Glaukos (GKOS) Stock Looks Pricey On High Growth Expectations - Sahm
BlackRock Inc. Takes Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos Corp stock hits all-time high at 190.27 USD By Investing.com - Investing.com South Africa
Glaukos director Kliman sells $475,000 in shares - Investing.com
Glaukos (NYSE:GKOS) Director Gilbert Kliman Sells 2,500 Shares of Stock - MarketBeat
Glaukos (NYSE: GKOS) director sells shares after option exercise - Stock Titan
GKOS Stock Surges 67% Year to Date: What's Driving the Rally? - Yahoo Finance
Glaukos Corp stock hits all-time high at 190.27 USD - Investing.com
BTIG Research Boosts Glaukos (NYSE:GKOS) Price Target to $202.00 - MarketBeat
Zacks Research Has Negative Outlook for Glaukos Q2 Earnings - MarketBeat
GKOS Maintained by BTIG -- Price Target Raised to $202 - GuruFocus
Glaukos (NYSE:GKOS) Reaches New 12-Month HighShould You Buy? - MarketBeat
Glaukos (NYSE: GKOS) holder to sell 2,500 shares in 2026 - Stock Titan
Here's Why You Should Retain Glaukos Stock in Your Portfolio for Now - Yahoo Finance
Glaukos Announces Participation in Wells Fargo Healthcare Conference - Business Wire
145,202 Shares in Glaukos Corporation $GKOS Bought by TimesSquare Capital Management LLC - MarketBeat
Glaukos Market Cap More Than Doubles in a Year to $11B - Orange County Business Journal
Glaukos Corporation (NYSE:GKOS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Oppenheimer Asset Management Inc. Invests $2.73 Million in Glaukos Corporation $GKOS - MarketBeat
3 Stocks That May Be Trading Below Their Estimated Value By Up To 50% - Sahm
Walleye Capital LLC Takes $3.75 Million Position in Glaukos Corporation $GKOS - MarketBeat
Glaukos Insider Sold Shares Worth $10,784,659, According to a Recent SEC Filing - marketscreener.com
Glaukos COO Joseph Gilliam sells $10.7m in stock By Investing.com - Investing.com Canada
Insider Selling: Glaukos (NYSE:GKOS) COO Sells 60,000 Shares of Stock - MarketBeat
Glaukos COO Joseph Gilliam sells $10.7m in stock - Investing.com
Glaukos(GKOS.US) Officer Sells US$10.78 Million in Common Stock - Moomoo
Glaukos Corporation (GKOS) Stock Forecasts - Yahoo! Finance Canada
Glaukos (NYSE:GKOS) Hits New 12-Month HighHere's What Happened - MarketBeat
Glaukos Corp stock hits all-time high at 184.45 USD - Investing.com
Glaukos Corp stock hits all-time high at 184.45 USD By Investing.com - Investing.com Canada
0.86%
0.13%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):